Gastrointestinal Oncology
A section of Current Oncology (ISSN 1718-7729).
Section Information
Gastrointestinal (GI) cancers, which include cancers of the esophagus, stomach, liver, pancreas and colorectum, account for significant cancer-related morbidity and mortality. In recent years, there have been remarkable advances aimed at improving the understanding, diagnosis and management of GI cancers. This section of Current Oncology aims to highlight the latest research on advances in GI cancers and welcomes original and review articles covering the spectrum from prevention and diagnosis to treatment and supportive care.
Keywords
- Epidemiology/risk factors
- Screening and prevention
- Diagnostic approaches and technologies
- Precision oncology, biomarkers
- Novel treatment approaches
- Clinical trials and real-world studies
- Research on health services and care delivery
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Novel Targeted Therapy, Immunotherapy, and Immune Biomarkers for Gastroesophageal and Liver Cancer (Deadline: 31 December 2024)
- Gastrointestinal Cancers in Eastern Canada (Deadline: 31 December 2024)
- Biliary Tract Cancer Updates: Advancements and Insights (Deadline: 31 December 2024)
- Novel Biomarkers and Liver Cancer (Deadline: 15 January 2025)
- Radioembolization for Hepatocellular Carcinoma (Deadline: 10 February 2025)
- Biomarkers and Precision Medicine in Upper Gastrointestinal Malignancies (Deadline: 30 April 2025)
- Recent Advances in Surgical Strategies for Managing Metastatic Colorectal Cancer (Deadline: 15 May 2025)
- Research on Neoadjuvant Therapy for Gastric Cancer (Deadline: 31 May 2025)
- Therapeutic Studies from Pre-Clinical to Clinical (Phase I–IV) for Gastrointestinal Cancers (Deadline: 30 June 2025)
- Histological and Molecular Subtype of Pancreatic Cancer (Deadline: 31 July 2025)
